Waters and Labcorp to expand access to cervical cancer screening with BD Onclarity HPV assay

LH•2026-10-23

Waters and Labcorp plan to offer the BD Onclarity HPV assay by the end of 2026, describing it as the most comprehensive FDA-approved HPV testing option.

Waters and Labcorp to expand access to cervical cancer screening with BD Onclarity HPV assay

1. Screening access plans

Related News

Inspired Entertainment, Inc.: B. Riley cuts target price to $8.75 from $13

Phillips Edison & Company target price cut to $40 from $41 by Wells Fargo

Preferred Bank's Q3 net interest income falls due to nonaccrual loans

Archer Aviation to display Midnight aircraft at Formula 1 Grand Prix

First Hawaiian declares quarterly dividend of $0.26 per share